Sorainen advised a renowned UK law firm on behalf of its client, an American clinical-stage biopharmaceutical company. The advice concerned clinical trials – our team helped to localise a complex agreement on clinical trials between Belarusian state clinics and the contract research organisation. Apart from its complexity, the project was remarkable since it happened against the backdrop of amendments to clinical trial regulations in Belarus. Head of the Life Sciences sector group Marina Golovnitskaya and associate Yauheni Budchanka handled this project.
More like this
-
Straumann Group acquires Med Grupė’s businesses in the Baltics
Deals & Cases / Sergej Butov, Jonas Kiauleikis, Monika Mališauskaitė-Vaupšienė, Gerda Skirbutienė, Aliaksei Vashkevich, Aurelija Daubaraitė, Sidas Sokolovas, Erika Žigutė, Jurgita Tekorienė, Danas Šniutė, Povilas Užkuraitis, Nedas Tamašauskas, Aija Lasmane, Kristīne Erele, Māris Simulis, Natālija Ešenberga, Piret Lappert, Liisa Maria Kuuskmaa, Verner Silm, Kristi Tammiku